echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Food News > Food Articles > Guangzhou Institute of Biology, Chinese Academy of Sciences discovers a new switch that regulates the pluripotency of embryonic stem cells

    Guangzhou Institute of Biology, Chinese Academy of Sciences discovers a new switch that regulates the pluripotency of embryonic stem cells

    • Last Update: 2021-03-18
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    Guangzhou Institute of Biology, Chinese Academy of Sciences discovers a new switch that regulates the pluripotency of embryonic stem cells
    The Guangzhou Institute of Biology of the Chinese Academy of Sciences discovered a new switch to regulate the pluripotency of embryonic stem cells The Guangzhou Institute of Biology of the Chinese Academy of Sciences discovered a new switch to regulate the pluripotency of embryonic stem cells

    Beijing time on March 4, 2021, Zhong Keyuan Guangzhou Institutes of Biomedicine and Health research team in "Nature" (Nature) magazine entitled "RNA m 6 A Reader YTHDC1 silences retrotransposons and the Cell Guards ES the Identity," published papers, Discovered a new switch that regulates the pluripotency of embryonic stem cells: RNA m 6 A reader protein YTHDC1 can regulate the formation of heterochromatin and affect the pluripotency of mouse embryonic stem cells.


    Zhong ASTRI ASTRI 6 6

    m 6 A is the most abundant modification on RNA, and it has attracted much attention because it regulates the processes of splicing, transport, degradation, and translation of RNA.


    6 6 6

    This work first constructed a mouse embryonic stem cell line with Ythdc1 conditionally knocked out, and found that the transcriptome of Ythdc1-cKO cells was obviously activated by the expression of TEs silenced by H3K9me3 (including IAP and LINE1), and H3K9me3 on these TEs The signal is greatly reduced, indicating that YTHDC1 and H3K9me3 are in a regulatory relationship.


    6 6 6

    The research team also found that the above-mentioned mechanism plays a key role in maintaining the stemness of embryonic stem cells.


    6

    Different from the pluripotency of embryonic stem cells, 2C-like cells have developmental totipotency.


    The discovery of this work provides important enlightenment for understanding how RNA regulates chromatin in mammals, and also promotes a further understanding of the biological functions of RNA m 6 A modification, as well as the maintenance and transformation of the pluripotency and pluripotency of stem cells.


    6

    China Ke Xueyuan Guangzhou Institutes of Biomedicine and Health researcher Jay Chen Kai-oriented co-first author of the paper corresponding author, PhD student Liu Jiadong, Gau Island Biological Laboratory and Wei He Jiangping Research Associate oriented papers.


    Academy of Sciences

    Related paper information: org/10.


    org/10.
    1038/s41586-021-03313-9" target="_blank">https://doi.
    org/10.
    1038/s41586-021-03313-9
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.